thymoquinone

N/A

Report date: 2025/06/10 17:55:00

Base Information

Drug Namethymoquinone
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionApoptosis stimulantsPolo like kinase 1 inhibitors
TargetsPolo like kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCeptaris Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCeptaris Therapeutics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A